Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$26.05 - $37.48 $794,967 - $1.14 Million
-30,517 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$24.46 - $40.92 $7.36 Million - $12.3 Million
-300,946 Reduced 90.79%
30,517 $1.08 Million
Q4 2021

Feb 14, 2022

SELL
$35.0 - $45.94 $2.13 Million - $2.8 Million
-60,898 Reduced 15.52%
331,463 $13.9 Million
Q3 2021

Nov 15, 2021

SELL
$36.8 - $60.62 $2.23 Million - $3.67 Million
-60,583 Reduced 13.38%
392,361 $19.3 Million
Q2 2021

Aug 16, 2021

SELL
$32.46 - $45.0 $1.98 Million - $2.75 Million
-61,013 Reduced 11.87%
452,944 $18.9 Million
Q1 2021

May 17, 2021

SELL
$25.8 - $38.49 $2.72 Million - $4.05 Million
-105,260 Reduced 17.0%
513,957 $18.3 Million
Q4 2020

Feb 16, 2021

BUY
$24.5 - $30.86 $15.2 Million - $19.1 Million
619,217 New
619,217 $17.4 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $723M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.